StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) income statement

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2024, quý kết thúc ngày Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences Holdings, Inc. income statement

Ratios

Latest available, balances at Mar 31, 2024

Profitability, TTM

Gross margin
56.5%
Operating margin
-192.2%
Net margin
-277.5%
Return on equity, FY2023
153.6%

Financial strength

Current ratio
0.23
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.5%

Valuation

P/E ratio
–
Price to sales
0.42
Price to book
–
Dividend yield
–

See a number that looks wrong?